ArticleKidney medicine2026
Five-Year Risk Prediction Models for Peripheral Artery Disease in Patients With Chronic Kidney Disease.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
Rationale & Objective: Patients with chronic kidney disease (CKD) have an increased risk of peripheral artery disease (PAD), yet no PAD risk-prediction models currently exist for this population. We developed and internally validated 5-year PAD risk-prediction models for individuals with CKD. Study Design: Prospective cohort study. Setting & Participants: 3,076 patients with CKD without PAD from the Chronic Renal Insufficiency Cohort (CRIC) study. Exposure: Clinically available variables, ankle-brachial index (ABI), and non-routinely measured cardiovascular disease biomarkers assessed at baseline. Outcomes: New-onset adjudicated clinical PAD event or an ABI ≤0.9 at an annual follow-up visit. Analytical Approach: Cox proportional hazards models were applied to estimate 5-year risk of incident PAD from baseline. Model performance was assessed by discrimination, calibration, and net reclassification improvement. All models were internally validated using Monte Carlo cross-validation. Results: Participants had a mean age of 57 years; 55% were male and 40% were Black. Over 5 years, 512 developed PAD. Compared with an ABI-only model that included ABI, age, and sex (area under the receiver operating characteristic curve [AUC], 0.697; 95% CI, 0.688-0.713), a clinical model using routine variables showed similar discrimination (AUC, 0.682; 95% CI, 0.669-0.691; Limitations: Lack of external validation. Conclusions: A PAD risk prediction model that combines clinical variables with ABI improves the identification of patients with CKD at high risk for PAD better than ABI alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.